BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Baxter
Julphar
QuintilesIMS
Fuji
Johnson and Johnson
US Army
AstraZeneca
Citi
Chubb

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020599

« Back to Dashboard

NDA 020599 describes RILUTEK, which is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from four suppliers. Additional details are available on the RILUTEK profile page.

The generic ingredient in RILUTEK is riluzole. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the riluzole profile page.
Summary for 020599
Tradename:RILUTEK
Applicant:Covis Pharma Bv
Ingredient:riluzole
Patents:0
Therapeutic Class:Central Nervous System Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020599
Ingredient-typeBenzothiazoles
Medical Subject Heading (MeSH) Categories for 020599
Suppliers and Packaging for NDA: 020599
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RILUTEK riluzole TABLET;ORAL 020599 NDA sanofi-aventis U.S. LLC 0075-7700 0075-7700-60 60 TABLET, FILM COATED in 1 BOTTLE (0075-7700-60)
RILUTEK riluzole TABLET;ORAL 020599 NDA KAISER FOUNDATION HOSPITALS 0179-0143 0179-0143-70 30 TABLET in 1 BOX, UNIT-DOSE (0179-0143-70)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Dec 12, 1995TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Healthtrust
Teva
Mallinckrodt
Express Scripts
Novartis
Chinese Patent Office
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot